Polycystic Kidney Disease: Basic, Translational, and Clinical Science

多囊肾病：基础科学、转化科学和临床科学

• 批准号: 7541112
• 负责人: ROBERT L BACALLAO
• 金额: $ 3万
• 依托单位: FEDERATION OF AMER SOC FOR EXPER BIOLOGY
• 依托单位国家: 美国
• 财政年份: 2008
• 资助国家: 美国
• 起止时间: 2008-07-01 至 2009-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7541112
• 关键词: American; Biological Markers; Clinical; Clinical Sciences; Cystic Kidney Diseases; Genes; Goals; Molecular; Physicians; Polycystic Kidney Diseases; Purpose; Research Personnel; Scientist; Signal Pathway; Societies; Therapeutic; insight; novel; programs

DESCRIPTION (provided by applicant): This application seeks support for a meeting sponsored by the Federation of American Society of Experimental Biologists that will be focused on Polycystic Kidney Disease. The purpose of this meeting is to gather basic, translational and clinical scientists in a common meeting to share the latest findings in the field of polycystic kidney disease. This is the third PKD meeting sponsored by FASEB and it has commitments from 52 speakers to attend the meeting. Of the 52 speakers, one fourth will be new/young investigators. The goals of this meeting are to; 1) present recent advances in defining genes, molecular signaling pathways and pathogenic mechanisms involved in renal cystic diseases, 2) Evaluate how basic mechanisms may provide insights into developing novel therapies and biomarkers, 3) Provide a program that integrates basic, applied and therapeutic themes so physician-scientists, basic researchers and clinicians sharing this information can frame new experimental challenges and pressing experimental questions.

描述（由申请人提供）： 该申请寻求对美国实验生物学家协会联合会主办的会议的支持，该会议将重点关注多囊肾疾病。本次会议的目的是聚集基础，翻译和临床科学家在一个共同的会议上分享多囊肾疾病领域的最新发现。这是FASEB主办的第三次PKD会议，有52位发言人承诺参加会议。在52名发言者中，四分之一将是新的/年轻的调查员。本次会议的目标是：1）介绍在定义基因，分子信号通路和肾囊肿疾病中涉及的致病机制方面的最新进展，2）评估基本机制如何为开发新的疗法和生物标志物提供见解，3）提供整合基础，应用和治疗主题的计划，以便医生科学家，基础研究人员和临床医生分享这些信息可以提出新的实验挑战和紧迫的实验问题。